Status:
COMPLETED
Group-Based Contingency Management for Substance Abuse Treatment - 1
Lead Sponsor:
UConn Health
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Substance Abuse
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of prize-based contingency management (CM) when administered exclusively in groups. Substance dependent patients (N=360) at community-based treatm...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- age \> 18 years
- current DSM-IV diagnosis of cocaine, opioid or alcohol abuse or dependence
- willing to provide breath and urine samples for 12 weeks
- English speaking
- willing to sign informed consent
- Exclusion criteria:
- serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk)
- dementia (\<23 on the Mini Mental State Exam; Folstein et al. 1975)
- in recovery from pathological gambling
Exclusion
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
312 Patients enrolled
Trial Details
Trial ID
NCT00249717
Start Date
May 1 2005
End Date
January 1 2010
Last Update
November 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Connecticut Health Center
Farmington, Connecticut, United States, 06030